Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred

12 Issues per year


IMPACT FACTOR 2016: 3.273

CiteScore 2016: 3.01

SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751

Online
ISSN
1437-4315
See all formats and pricing
In This Section
Volume 383, Issue 9 (Sep 2002)

Issues

Kaposis Sarcoma and Human Chorionic Gonadotropin: Mechanisms, Moieties and Mysteries

D. Bisacchi / D. M. Noonan / S. Carlone / A. Albini / U. Pfeffer
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/BC.2002.149

Abstract

Kaposis Sarcoma (KS) is a highly angiogenic neoplasm associated with infection by the human γherpesvirus, HHV-8 or Kaposis sarcoma herpes virus (KSHV). When in 1872 the Hungarian scientist Moritz Kaposi described the sarcoma, which was later named after him, he was dealing with a rare dermatologic disease. Today, KS is a more common pathology due to its high incidence in AIDS, in immunosuppressed transplantation patients and, in its endemic form, in Africa. The introduction of highly active antiretroviral therapy (HAART) has led to a drastic reduction of KS incidence in HIVinfected patients, but in some cases KS resists the treatment. KS is more common in men than in women. The observation of spontaneous remissions during pregnancy stimulated investigations into the potential antiKS activity of the pregnancy hormone human chorionic gonadotropin (hCG). The variable effect in clinical trials using urinary preparations of the hormone (uhCG) has led to the hypothesis that contaminating moieties present in these preparations may account for the antiKS effect observed in vitro. While the discrepancy between laboratory tests and clinical trials remains a mystery, little is known about potential antiKS mechanisms of the hormone itself and/or other active moieties present in uhCG.

About the article

Published Online: 2005-06-01

Published in Print: 2002-09-17



Citation Information: Biological Chemistry, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2002.149. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Phillipo L. Chalya, Fidelis Mbunda, Peter F. Rambau, Hyasinta Jaka, Nestory Masalu, Mariam Mirambo, Martha F. Mushi, and Samuel E. Kalluvya
BMC Research Notes, 2015, Volume 8, Number 1
[2]
Robert A. Schwartz, Giuseppe Micali, Maria Rita Nasca, and Laura Scuderi
Journal of the American Academy of Dermatology, 2008, Volume 59, Number 2, Page 179
[3]
S.D. Keay, M. Vatish, E. Karteris, E.W. Hillhouse, and H.S. Randeva
BJOG: An International Journal of Obstetrics & Gynaecology, 2004, Volume 111, Number 11, Page 1218
[4]
L.-Y. Khil, H.-S. Jun, H. Kwon, J. K. Yoo, S. Kim, A. L. Notkins, and J.-W. Yoon
Diabetologia, 2007, Volume 50, Number 10, Page 2147

Comments (0)

Please log in or register to comment.
Log in